amitriptyline has been researched along with Puerperal Disorders in 2 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
Puerperal Disorders: Disorders or diseases associated with PUERPERIUM, the six-to-eight-week period immediately after PARTURITION in humans.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brixen-Rasmussen, L | 1 |
| Halgrener, J | 1 |
| Jørgensen, A | 1 |
| Pittard, WB | 1 |
| O'Neal, W | 1 |
2 other studies available for amitriptyline and Puerperal Disorders
| Article | Year |
|---|---|
Amitriptyline and nortriptyline excretion in human breast milk.
Topics: Adult; Amitriptyline; Depressive Disorder; Female; Humans; Milk, Human; Nortriptyline; Pregnancy; Pu | 1982 |
Amitriptyline excretion in human milk.
Topics: Adult; Amitriptyline; Depressive Disorder; Female; Humans; Infant, Newborn; Milk, Human; Pregnancy; | 1986 |